{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T12:05:05Z","timestamp":1765713905479},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T00:00:00Z","timestamp":1432598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0128032","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T18:12:01Z","timestamp":1432663921000},"page":"e0128032","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Comparison of Bone Mineral Density in Lumbar Spine and Fracture Rate among Eight Drugs in Treatments of Osteoporosis in Men: A Network Meta-Analysis"],"prefix":"10.1371","volume":"10","author":[{"given":"Ling-Xiao","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-Zhi","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Song","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Qing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,5,26]]},"reference":[{"issue":"9773","key":"ref1","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","article-title":"Osteoporosis: now and the future","volume":"377","author":"TD Rachner","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/BOR.0000000000000064","article-title":"Osteoporosis epidemiology 2013: implications for diagnosis, risk assessment, and treatment","volume":"26","author":"WD Leslie","year":"2014","journal-title":"Current opinion in rheumatology"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/gerona\/glt105","article-title":"Death, debility, and destitution following hip fracture","volume":"69","author":"GS Tajeu","year":"2014","journal-title":"The journals of gerontology Series A, Biological sciences and medical sciences"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/jbmr.2099","article-title":"Temporal trends in obesity, osteoporosis treatment, bone mineral density, and fracture rates: a population-based historical cohort study. Journal of bone and mineral research: the official journal of the","volume":"29","author":"WD Leslie","year":"2014","journal-title":"American Society for Bone and Mineral Research"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00198-011-1623-0","article-title":"Changes in femur neck bone density in US adults between 1988\u20131994 and 2005\u20132008: demographic patterns and possible determinants","volume":"23","author":"AC Looker","year":"2012","journal-title":"Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0889-8529(02)00024-5","article-title":"Summary of meta-analyses of therapies for postmenopausal osteoporosis and the relationship between bone density and fractures","volume":"31","author":"GH Guyatt","year":"2002","journal-title":"Endocrinology and metabolism clinics of North America"},{"issue":"9527","key":"ref7","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0140-6736(06)68891-0","article-title":"Osteoporosis","volume":"367","author":"P Sambrook","year":"2006","journal-title":"Lancet"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1056\/NEJMoa050157","article-title":"Daily and cyclic parathyroid hormone in women receiving alendronate","volume":"353","author":"F Cosman","year":"2005","journal-title":"The New England journal of medicine"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","article-title":"Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use","volume":"26","author":"AB Hodsman","year":"2005","journal-title":"Endocrine reviews"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00774-006-0738-4","article-title":"Clinical effect of bisphosphonate and vitamin D on osteoporosis: reappraisal of a multicenter double-blind clinical trial comparing etidronate and alfacalcidol","volume":"25","author":"T Fujita","year":"2007","journal-title":"Journal of bone and mineral metabolism"},{"issue":"1","key":"ref11","first-page":"34","article-title":"Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass","volume":"11","author":"D Felsenberg","year":"2011","journal-title":"Journal of musculoskeletal & neuronal interactions"},{"key":"ref12","unstructured":"HJ G. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaborationk, Available from <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/wwwcochrane-handbookorg\" xlink:type=\"simple\">wwwcochrane-handbookorg<\/ext-link>. 2011."},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2165\/00019053-200826090-00006","article-title":"Use of indirect and mixed treatment comparisons for technology assessment","volume":"26","author":"A Sutton","year":"2008","journal-title":"PharmacoEconomics"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/jama.2014.10397","article-title":"Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis","volume":"312","author":"BC Johnston","year":"2014","journal-title":"Jama"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"G Salanti","year":"2011","journal-title":"Journal of clinical epidemiology"},{"issue":"23","key":"ref16","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1002\/sim.1586","article-title":"Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling","volume":"22","author":"DJ Spiegelhalter","year":"2003","journal-title":"Statistics in medicine"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12020-012-9819-4","article-title":"Combination therapy with risedronate and teriparatide in male osteoporosis","volume":"44","author":"MD Walker","year":"2013","journal-title":"Endocrine"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1210\/jc.2012-3048","article-title":"Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men","volume":"98","author":"JM Kaufman","year":"2013","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"18","key":"ref19","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1056\/NEJMoa1204061","article-title":"Fracture risk and zoledronic acid therapy in men with osteoporosis","volume":"367","author":"S Boonen","year":"2012","journal-title":"The New England journal of medicine"},{"issue":"5","key":"ref20","first-page":"267","article-title":"Efficacy of strontium ranelate on bone mineral density in men with osteoporosis","volume":"60","author":"JD Ringe","year":"2010","journal-title":"Arzneimittel-Forschung"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/jbmr.119","article-title":"Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study","volume":"25","author":"ES Orwoll","year":"2010","journal-title":"Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.bone.2009.12.034","article-title":"Efficacy and safety of monthly ibandronate in men with low bone density","volume":"46","author":"ES Orwoll","year":"2010","journal-title":"Bone"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00296-008-0689-2","article-title":"Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study","volume":"29","author":"JD Ringe","year":"2009","journal-title":"Rheumatology international"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1359\/jbmr.081214","article-title":"Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study","volume":"24","author":"S Boonen","year":"2009","journal-title":"Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00198-004-1713-3","article-title":"Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy","volume":"16","author":"JM Kaufman","year":"2005","journal-title":"Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00296-003-0388-y","article-title":"Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study","volume":"24","author":"JD Ringe","year":"2004","journal-title":"Rheumatology international"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1210\/jcem.86.11.7988","article-title":"Alendronate treatment of established primary osteoporosis in men: results of a 2-year prospective study","volume":"86","author":"JD Ringe","year":"2001","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1056\/NEJM200008313430902","article-title":"Alendronate for the treatment of osteoporosis in men","volume":"343","author":"E Orwoll","year":"2000","journal-title":"The New England journal of medicine"},{"issue":"9","key":"ref29","first-page":"3069","article-title":"Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers","volume":"85","author":"ES Kurland","year":"2000","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"3","key":"ref30","first-page":"402","article-title":"Treatment of osteoporosis in men using dehydroepiandrosterone sulfate","volume":"115","author":"Y Sun","year":"2002","journal-title":"Chinese medical journal"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00774-009-0136-9","article-title":"The effects of weekly alendronate therapy in Taiwanese males with osteoporosis","volume":"28","author":"JS Hwang","year":"2010","journal-title":"Journal of bone and mineral metabolism"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00045391-199803000-00006","article-title":"Nandrolone decanoate for men with osteoporosis","volume":"5","author":"RC Hamdy","year":"1998","journal-title":"American journal of therapeutics"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s001980050047","article-title":"Avoidance of vertebral fractures in men with idiopathic osteoporosis by a three year therapy with calcium and low-dose intermittent monofluorophosphate","volume":"8","author":"JD Ringe","year":"1998","journal-title":"Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/PL00004182","article-title":"Effects of alendronate on bone density in men with primary and secondary osteoporosis","volume":"11","author":"YV Ho","year":"2000","journal-title":"Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00223-001-1066-2","article-title":"Alendronate for the treatment of osteoporosis in men","volume":"69","author":"S Adami","year":"2001","journal-title":"Calcified tissue international"},{"issue":"11","key":"ref36","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1210\/jc.2002-020231","article-title":"Two years of treatment with recombinant human growth hormone increases bone mineral density in men with idiopathic osteoporosis","volume":"87","author":"P Gillberg","year":"2002","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"13","key":"ref37","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","article-title":"The effects of parathyroid hormone, alendronate, or both in men with osteoporosis","volume":"349","author":"JS Finkelstein","year":"2003","journal-title":"The New England journal of medicine"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00223-002-1085-7","article-title":"Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study","volume":"73","author":"S Gonnelli","year":"2003","journal-title":"Calcified tissue international"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","article-title":"The effect of teriparatide [human parathyroid hormone (1\u201334)] therapy on bone density in men with osteoporosis","volume":"18","author":"ES Orwoll","year":"2003","journal-title":"Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00296-005-0004-4","article-title":"Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study","volume":"26","author":"JD Ringe","year":"2006","journal-title":"Rheumatology international"},{"issue":"4","key":"ref41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/13685530701661051","article-title":"The effects of daily alendronate, daily calcitonin and alendronate every other day on bone mineral density in osteoporotic men","volume":"10","author":"Z Guven","year":"2007","journal-title":"The aging male: the official journal of the International Society for the Study of the Aging Male"},{"issue":"8","key":"ref42","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2169\/internalmedicine.47.0591","article-title":"Efficacy of risedronate in Japanese male patients with primary osteoporosis","volume":"47","author":"T Majima","year":"2008","journal-title":"Internal medicine"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bone.2012.06.016","article-title":"Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study","volume":"51","author":"S Boonen","year":"2012","journal-title":"Bone"},{"issue":"12","key":"ref44","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3109\/09513590.2013.813468","article-title":"Systematic review and meta-analysis of the efficacy and safety of alendronate and zoledronate for the treatment of postmenopausal osteoporosis","volume":"29","author":"AJ Serrano","year":"2013","journal-title":"Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology"},{"issue":"5","key":"ref45","first-page":"658","article-title":"Ranking antireabsorptive agents to prevent vertebral fractures in postmenopausal osteoporosis by mixed treatment comparison meta-analysis","volume":"17","author":"A Migliore","year":"2013","journal-title":"European review for medical and pharmacological sciences"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00198-012-2068-9","article-title":"Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis","volume":"24","author":"N Freemantle","year":"2013","journal-title":"Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"259818","DOI":"10.4061\/2011\/259818","article-title":"The evidence for efficacy of osteoporosis treatment in men with primary osteoporosis: a systematic review and meta-analysis of antiresorptive and anabolic treatment in men","volume":"2011","author":"P Schwarz","year":"2011","journal-title":"Journal of osteoporosis"},{"issue":"10","key":"ref48","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician&apos;s Guide to Prevention and Treatment of Osteoporosis","volume":"25","author":"F Cosman","year":"2014","journal-title":"Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"Suppl 3","key":"ref49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.16.S3.1","article-title":"American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis","volume":"16","author":"NB Watts","year":"2010","journal-title":"Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists"},{"key":"ref50","unstructured":"Hospital MG. Effects of Parathyroid Hormone in Men With Osteoporosis. NCT00000427. 2013."},{"key":"ref51","unstructured":"Institutet K. Cohort of Swedish Men (COSM). NCT01127711. 2014."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0128032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T05:40:19Z","timestamp":1540273219000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0128032"}},"subtitle":[],"editor":[{"given":"Bart O.","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,26]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0128032","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,26]]}}}